A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect ...

Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which has repeatedly shown ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

YourChoice Therapeutics has dosed the first cohort of male subjects in a Phase Ia/IIb clinical trial of YCT-529, a ...

Dr. Jeremy Farrar, WHO’s Chief Scientist, emphasized the importance of strengthening country-led R&D and integrating clinical ...

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondriaIn ...

These RSV animal model services allow scientists to evaluate the immunogenicity and efficacy of potential RSV vaccine ...

The option gives Glaukos exclusive global license agreements on pre-agreed terms, including upfront and milestone payments ...

PharmaLegacy Laboratories, a provider of in vitro and in vivo preclinical drug development services, has acquired BTS ...

Vivani Medical today announced that Australian authorities approved a first-in-human clinical trial for its subdermal GLP-1 ...